Periprosthetic Joint Infection (PJI) is one of the greatest
challenges in orthopaedics. Despite technological advances in implant
design and surgical techniques, the overall incidence of PJI is
steadily increasing.1 Moreover, the occurrence of culture
negative infections, inflammatory conditions / other comorbidities,
and premature administration of antibiotics, all present obstacles to
the clinical diagnosis of PJI.
Zimmer Biomet is committed to helping surgeons and infection specialists improve management of PJI with the use of diagnostics.
Our proprietary synovial fluid tests aim to facilitate diagnosis of PJI, by detecting unique local biomarkers (or proteins), which measure the body’s specific response to disease.